Fact Based List:
Justin Smerker, PharmD, MSPBA: Challenges for Value-Based Contracting in Specialty Pharmacy
Submitted by Charlene Ice on Fri, 05/05/2017 - 11:35
- anti-kickback statutes create uncertainty between manufacturers and payers
- data elements required would need to be specific to each type of drug therapy
- lack of technology that allows manufacturers and payers to communicate effectively during the prior authorization and maintenance process for specialty medications
- health plans would have to share data about their members with manufacturers
- firewalls in place to prevent a health plan from acquiring patient specific information
- a number of HIPAA laws in place that may prevent or complicate the sharing of information
Source: Specialty Pharmacy Times, May 1, 2017
Source URL: https://www.specialtypharmacytimes.com/news/challenges-for-v...
List Ratings: |
Lists You Might Also Be Interested In
- Daniel Faggella: 7 Applications of Machine Learning in Pharma and Medicine
- D2: 7 Key Factors Impacting Value-Based Contracting Between Plans/PBMs and Pharma or Medical Device Manufacturers
- KPMG: Ten Imperatives for Pharmaceutical Commercial Transformation
- Five things pharma should know about cardiologists - DRG Digital Innovation Blog
- Top Five Pharmaceutical Companies by Sales and R&D Spending (2020 $US Dollars)
Login or register to post comments